...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith AGM?

How did you guys and gals like the AGM?? In respect to a listing well thats not going to happen anytime soon,,,,again,,,,hoarding and disrespecting the retail shareholders wishes,,for some reason,,but of course expected!

Lots of activity going on even in very opposition to the idea that RVX is stagnated due to covid19 restrictions. Seems trials and other is a none issue with Zenith's partners. That maybe the biggest clue so far,,partners see urgency but our management have none!

Anyway it looks to have much more intrinsic value than RVX at the moment! jmo

Share
New Message
Please login to post a reply